Biosolution Co Ltd
086820
Company Profile
Business description
Biosolution Co Ltd is a Korean company offering Cell-Based Biotechnology. It is engaged in manufacturing and selling cell therapy products, and developing cell therapeutics technology. Its main areas include cell-based therapeutics with their background in somatic and stem cell technology, and the manufacturing, sales, and R&D of human tissue models for screening toxicity and efficacy with tissue engineering technology.
Contact
Gongneung-Ro 232, Nowon-gu
5th Floor, Room 519, Seoul Technopark
Seoul
KORT: +82 234468884
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
84
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,690.90 | 53.40 | 0.62% |
CAC 40 | 7,763.84 | 26.64 | 0.34% |
DAX 40 | 24,091.62 | 160.95 | 0.67% |
Dow JONES (US) | 42,519.64 | 214.16 | 0.51% |
FTSE 100 | 8,787.02 | 12.76 | 0.15% |
HKSE | 23,512.49 | 354.52 | 1.53% |
NASDAQ | 19,398.96 | 156.34 | 0.81% |
Nikkei 225 | 37,446.81 | 23.86 | -0.06% |
NZX 50 Index | 12,371.18 | 43.95 | 0.36% |
S&P 500 | 5,970.37 | 34.43 | 0.58% |
S&P/ASX 200 | 8,466.70 | 52.60 | 0.63% |
SSE Composite Index | 3,361.98 | 14.49 | 0.43% |